Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Klaria Pharma Holding AB: Klaria Annual Report 2024

Klaria Pharma Holding
Download the release

Klaria Pharma Holding AB Annual Report 2024

The year in brief

- Net sales amounted to 2.2 MSEK (8.5 MSEK)

- Other operating income amounted to 0.1 MSEK (0.5 MSEK)

- R&D costs amounted to 22.1 MSEK (25.0 MSEK)

- Profit/loss after tax amounted to -47.8 MSEK (-35.8 MSEK)

- Earnings per share amounted to -0.38 SEK (-0.36 SEK)

- Cash flow from operations amounted to -11.9 MSEK (-9.1 MSEK)

- Shareholder's equity as of December 31, 2024 amounted to 3.3 MSEK (41.1 MSEK)

- Cash and cash equivalents as of December 31, 2024 amounted to 0.6 MSEK (1.2 MSEK)

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.